ea0034p349 | Steroids | SFEBES2014
O'Reilly Michael
, Taylor Angela
, Crabtree Nicola
, Hughes Beverly
, Capper Farfia
, Crowley Rachel
, Stewart Paul
, Tomlinson Jeremy
, Arlt Wiebke
Polycystic ovary syndrome (PCOS) is a clinical triad of anovulation, insulin resistance, and androgen excess. Hyperandrogenism may correlate with metabolic risk but PCOS consensus criteria currently define androgen excess on the basis of serum testosterone only. Here we studied the utility of the androgen precursor serum androstenedione in conjunction with serum testosterone as a predictor of metabolic dysfunction in PCOS.86 PCOS patients fulfilling Rott...